SHEEL (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE circular announcing inclusion of 5 securities under Long Term ASM Stage-I and movement of 4 securities from Stage-I to Stage-II, … | |||||||||||||||
NSE circular announcing inclusion of 5 securities under Long Term ASM Stage-I and movement of 4 securities from Stage-I to Stage-II, effective April 13-16, 2026, with 100% margin requirement.
| |||||||||||||||
NSE announces inclusion of three securities under Long-Term ASM Stage I and one security moving to Stage II, effective April 02, 2026, with … | |||||||||||||||
NSE announces inclusion of three securities under Long-Term ASM Stage I and one security moving to Stage II, effective April 02, 2026, with 100% margin requirement from April 07, 2026.
| |||||||||||||||
Sheel Biotech Limited to be transferred from trade for trade segment (series: ST) to rolling segment (Series: SM) effective October 24, … | |||||||||||||||
Sheel Biotech Limited to be transferred from trade for trade segment (series: ST) to rolling segment (Series: SM) effective October 24, 2025.
| |||||||||||||||
NSE announces listing of Sheel Biotech Limited equity shares on EMERGE SME Platform effective October 08, 2025, with trade-for-trade … | |||||||||||||||
NSE announces listing of Sheel Biotech Limited equity shares on EMERGE SME Platform effective October 08, 2025, with trade-for-trade surveillance segment.
| |||||||||||||||